Chemoinformaics analysis of Aminobutylhomospermidine
| Molecular Weight | 230.4 | nRot | 13 |
| Heavy Atom Molecular Weight | 200.16 | nRig | 0 |
| Exact Molecular Weight | 230.247 | nRing | 0 |
| Solubility: LogS | 0.601 | nHRing | 0 |
| Solubility: LogP | -0.344 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 4 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 44.4438 |
| nHD | 4 | BPOL | 30.0962 |
| QED | 0.346 |
| Synth | 2.024 |
| Natural Product Likeliness | 0.104 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.45 |
| Pgp-sub | 0.997 |
| HIA | 0.448 |
| CACO-2 | -6.21 |
| MDCK | 0.00000268 |
| BBB | 0.08 |
| PPB | 0.344383 |
| VDSS | 0.696 |
| FU | 0.895802 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.033 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.258 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.021 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.906 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.277 |
| CL | 6.574 |
| T12 | 0.19 |
| hERG | 0.086 |
| Ames | 0.027 |
| ROA | 0.355 |
| SkinSen | 0.961 |
| Carcinogencity | 0.008 |
| EI | 0.064 |
| Respiratory | 0.763 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.724391 |